Member access

4-Traders Homepage  >  Shares  >  Euronext Alternext  >  MEDIAN TECHNO    ALMDT   FR0011049824


News SummaryMost relevantAll newsSector news 

MEDIANTECHNOLOGIES : MEDIAN Technologies Names Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America

04/04/2012 | 01:35am US/Eastern

Ciaran Cooper will be responsible for developing the company's US market in oncology clinical trials and will assist in managing the relationship between MEDIAN and Quintiles

Regulatory News:

MEDIAN Technologies (Paris:ALMDT), a leading medical imaging software solutions developer, and a service provider for image interpretation and management in oncology clinical trials, announced today that it has named Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America. Ciaran Cooper will be responsible for developing the company's US market in oncology clinical trials and will assist in managing the strategic relationship between MEDIAN Technologies and Quintiles.

Ciaran Cooper, an entrepreneur and early innovator in the clinical trials imaging services industry, brings over 20 years' experience in medical imaging with an emphasis in business development, strategic planning, and team management. Along with colleagues from the University of Chicago, Ciaran Cooper co-founded MIICRO, Inc. in 1995, the first imaging CRO specialized in early phase translational imaging with FDG PET. He was CEO of MIICRO until 2003. Since then, Ciaran Cooper has worked for several imaging services and technology companies as a senior manager in business development and thus brings with him a vast knowledge of various business models, therapeutic areas, and growth strategies.

"I'm very excited to join MEDIAN at this time in their development," said Ciaran Cooper. "MEDIAN's LMS solution provides a quantum leap forward in how medical imaging can be applied to oncology clinical trials. I look forward to carrying our message to market."

"We're thrilled to welcome Ciaran to our team," said Jerome Windsor, VP Business Development at MEDIAN Technologies. "Ciaran has a unique perspective on the industry and he brings an entrepreneurial spirit and enthusiasm that will fit well with our growing company."

About MEDIAN Technologies: MEDIAN Technologies provides advanced imaging solutions for diagnosing and monitoring cancer patients in clinical trials and in routine clinical practice. MEDIAN collaborates with institutes at the cutting edge of medical imaging, including the French National Institute for Computer Science and Control (INRIA), the University of Chicago, and the Swiss Federal Institute of Technology in Lausanne, Switzerland (EPFL). MEDIAN is present in the market through direct and indirect sales of its LMS solutions and through alliances with specialist cancer centers in Europe and the USA. MEDIAN has a strategic partnership with Quintiles, to offer integrated imaging services for clinical trials to customers worldwide.

Based in Sophia Antipolis, France, MEDIAN was founded in 2002 by Fredrik Brag (Current CEO), Gérard Milhiet, and Arnaud Butzbach. The company has a staff of 40, over half of whom work in R&D, and has a US-based subsidiary.

For more information on MEDIAN, please visit:

MEDIAN Technologies
Fredrik Brag, CEO
+33 4 92 90 65 82
Press - ALIZE RP
Caroline Carmagnol
+ 33 6 64 18 99 59 // + 33 1 42 68 86 43
Anne-Sophie Cosquéric
+ 33 1 42 68 86 41

© Business Wire 2012
React to this article
Latest news on MEDIAN TECHNO
03/03 MEDIAN TECHNO : New Projects for Image Interpretation and Management in Clinical..
02/19 MEDIAN TECHNO : ogies : to Present at Cowen and Company 35TH Health Care Confere..
02/17 MEDIAN TECHNO : ogies : A €11M Order Backlog for 2014, More Than Doubled as Comp..
01/26 MEDIAN TECHNO : ogies :’ Semiannual Balance Sheet for the Liquidity Contra..
01/23 MEDIAN TECHNO : ogies : Financial Communications Schedule for the First Half of ..
2014 MEDIAN TECHNO : ogies : to Take Part in the Annual 2014 Meeting of the RSNA in C..
2014 MEDIAN TECHNO : Broadens Its Client Base with the Award of a New €2.2M Project f..
2014 MEDIAN TECHNO : ogies : 2014 First Half Results in Line with Expectations
2014 MEDIAN TECHNO : Steps up Its Development: New Project Awards and a New Contract ..
2014 MEDIAN TECHNO : ogies : Approval of the Reserved Capital Increase of €20 Million
Duration : Period :
MEDIAN TECHNO Technical Analysis Chart | ALMDT | FR0011049824 | 4-Traders
Dynamic quotes